US Stock MarketDetailed Quotes

KYMR Kymera Therapeutics

Watchlist

33.370
+0.020+0.06%

Close Apr 26 16:00 ET

2.05BMarket Cap-13242P/E (TTM)

Kymera Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

32.83%-102.83M

120.35%8.05M

7.65%-31.65M

9.57%-35.26M

-9.12%-43.97M

-18.72%-153.09M

-3.09%-39.54M

8.03%-34.27M

-27.77%-38.99M

-76.55%-40.3M

Net income from continuing operations

5.07%-146.96M

58.79%-14.37M

-22.94%-52.87M

3.62%-38.8M

-11.57%-40.93M

-54.47%-154.81M

-2.85%-34.87M

-50.45%-43M

-63.25%-40.26M

-180.57%-36.68M

Operating gains losses

-688.19%-5.23M

----

-212.85%-1.33M

-84.74%889K

----

--1.18M

Depreciation and amortization

19.75%3.57M

8.92%891K

16.69%895K

27.66%900K

27.95%879K

24.20%2.98M

18.72%818K

14.31%767K

27.72%705K

41.65%687K

Change In working capital

107.13%2.68M

188.14%11.89M

1,039.83%9.89M

26.84%-7.12M

10.25%-11.98M

39.24%-37.62M

12.69%-13.49M

94.29%-1.05M

27.16%-9.73M

9.11%-13.35M

-Change in receivables

-575.80%-16.23M

-4,430.92%-14.99M

167.06%344K

27.49%-802K

30.59%-783K

-284.98%-2.4M

-75.94%346K

23.32%-513K

-233.25%-1.11M

-274.75%-1.13M

-Change in prepaid assets

-97.68%-1.96M

603.54%2.42M

66.37%-384K

-293.50%-2.35M

-180.03%-1.64M

75.30%-992K

83.72%-480K

-16.89%-1.14M

67.72%1.22M

28.19%-586K

-Change in payables and accrued expense

9.35%5.22M

975.45%8.32M

-51.63%3.66M

612.84%1.06M

-110.50%-7.82M

-62.29%4.77M

-72.04%774K

323.10%7.57M

-96.01%148K

-184.72%-3.72M

-Change in other current assets

827.85%4.8M

1,346.04%2.01M

450.38%732K

627.78%917K

856.30%1.14M

23.39%517K

21.93%139K

23.15%133K

23.53%126K

25.26%119K

-Change in other current liabilities

1,950.80%18.58M

1,192.86%2.91M

2,463.32%6.12M

2,734.52%6.64M

1,384.14%2.92M

1.08%-1M

-20.36%-266K

-20.47%-259K

-19.43%-252K

38.32%-227K

-Change in other working capital

79.94%-7.73M

180.11%11.22M

91.44%-585K

-27.49%-12.58M

25.89%-5.79M

45.95%-38.52M

15.66%-14.01M

62.96%-6.84M

46.74%-9.86M

55.83%-7.81M

Cash from discontinued investing activities

Operating cash flow

32.83%-102.83M

120.35%8.05M

7.65%-31.65M

9.57%-35.26M

-9.12%-43.97M

-18.72%-153.09M

-3.09%-39.54M

8.03%-34.27M

-27.77%-38.99M

-76.55%-40.3M

Investing cash flow

Cash flow from continuing investing activities

581.74%139.89M

138.16%18.95M

261.44%60.51M

-56.19%35.84M

-4.95%24.58M

120.55%20.52M

26.98%-49.67M

72.61%-37.48M

34.72%81.8M

-41.65%25.86M

Net PPE purchase and sale

-1,115.80%-34.48M

-3,016.62%-11.63M

-548.31%-8.08M

-1,365.03%-10.77M

-731.74%-4.01M

-77.58%-2.84M

25.55%-373K

-307.19%-1.25M

-17.41%-735K

-193.90%-482K

Net investment purchase and sale

646.59%174.37M

162.03%30.58M

289.29%68.59M

-43.53%46.61M

8.53%28.59M

123.77%23.36M

26.99%-49.29M

73.47%-36.24M

34.54%82.54M

-40.78%26.35M

Cash from discontinued investing activities

Investing cash flow

581.74%139.89M

138.16%18.95M

261.44%60.51M

-56.19%35.84M

-4.95%24.58M

120.55%20.52M

26.98%-49.67M

72.61%-37.48M

34.72%81.8M

-41.65%25.86M

Financing cash flow

Cash flow from continuing financing activities

-97.26%4.19M

-0.97%1.93M

-100.14%-206K

258.52%1.31M

526.49%1.16M

-38.87%153M

-4.92%1.95M

-38.83%150.5M

-77.14%364K

-68.91%185K

Net issuance payments of debt

93.27%-76K

403.28%925K

-16.44%-340K

-24.16%-334K

-23.86%-327K

-33.10%-1.13M

-95.51%-305K

17.05%-292K

-44.62%-269K

-70.32%-264K

Net common stock issuance

--0

----

-38.37%149.83M

--0

----

Proceeds from stock option exercised by employees

-0.84%4.27M

-55.31%1.01M

-86.10%134K

158.93%1.64M

230.96%1.49M

-48.88%4.3M

0.85%2.26M

-70.39%964K

-64.40%633K

-60.85%449K

Cash from discontinued financing activities

Financing cash flow

-97.26%4.19M

-0.97%1.93M

-100.14%-206K

258.52%1.31M

526.49%1.16M

-38.87%153M

-4.92%1.95M

-38.83%150.5M

-77.14%364K

-68.91%185K

Net cash flow

Beginning cash position

37.77%74.53M

-46.32%86.85M

-29.92%58.19M

41.30%56.3M

37.77%74.52M

65.96%54.09M

2.12%161.77M

-4.01%83.03M

-27.14%39.85M

65.96%54.09M

Current changes in cash

101.89%41.25M

133.16%28.93M

-63.61%28.66M

-95.63%1.89M

-27.92%-18.23M

-4.96%20.43M

16.36%-87.25M

9.50%78.75M

35.78%43.18M

-164.48%-14.25M

End cash Position

55.35%115.78M

-46.32%86.85M

-29.92%58.19M

41.30%56.3M

37.77%74.53M

2.12%161.77M

-4.01%83.03M

-27.14%39.85M

Free cash flow

11.94%-137.31M

91.03%-3.58M

-11.85%-39.73M

-15.87%-46.02M

-17.66%-47.98M

-19.44%-155.92M

-2.72%-39.91M

5.46%-35.52M

-27.57%-39.72M

-77.39%-40.78M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	32.83%-102.83M	120.35%8.05M	7.65%-31.65M	9.57%-35.26M	-9.12%-43.97M	-18.72%-153.09M	-3.09%-39.54M	8.03%-34.27M	-27.77%-38.99M	-76.55%-40.3M
Net income from continuing operations	5.07%-146.96M	58.79%-14.37M	-22.94%-52.87M	3.62%-38.8M	-11.57%-40.93M	-54.47%-154.81M	-2.85%-34.87M	-50.45%-43M	-63.25%-40.26M	-180.57%-36.68M
Operating gains losses	-688.19%-5.23M	----	----	----	-212.85%-1.33M	-84.74%889K	----	----	----	--1.18M
Depreciation and amortization	19.75%3.57M	8.92%891K	16.69%895K	27.66%900K	27.95%879K	24.20%2.98M	18.72%818K	14.31%767K	27.72%705K	41.65%687K
Change In working capital	107.13%2.68M	188.14%11.89M	1,039.83%9.89M	26.84%-7.12M	10.25%-11.98M	39.24%-37.62M	12.69%-13.49M	94.29%-1.05M	27.16%-9.73M	9.11%-13.35M
-Change in receivables	-575.80%-16.23M	-4,430.92%-14.99M	167.06%344K	27.49%-802K	30.59%-783K	-284.98%-2.4M	-75.94%346K	23.32%-513K	-233.25%-1.11M	-274.75%-1.13M
-Change in prepaid assets	-97.68%-1.96M	603.54%2.42M	66.37%-384K	-293.50%-2.35M	-180.03%-1.64M	75.30%-992K	83.72%-480K	-16.89%-1.14M	67.72%1.22M	28.19%-586K
-Change in payables and accrued expense	9.35%5.22M	975.45%8.32M	-51.63%3.66M	612.84%1.06M	-110.50%-7.82M	-62.29%4.77M	-72.04%774K	323.10%7.57M	-96.01%148K	-184.72%-3.72M
-Change in other current assets	827.85%4.8M	1,346.04%2.01M	450.38%732K	627.78%917K	856.30%1.14M	23.39%517K	21.93%139K	23.15%133K	23.53%126K	25.26%119K
-Change in other current liabilities	1,950.80%18.58M	1,192.86%2.91M	2,463.32%6.12M	2,734.52%6.64M	1,384.14%2.92M	1.08%-1M	-20.36%-266K	-20.47%-259K	-19.43%-252K	38.32%-227K
-Change in other working capital	79.94%-7.73M	180.11%11.22M	91.44%-585K	-27.49%-12.58M	25.89%-5.79M	45.95%-38.52M	15.66%-14.01M	62.96%-6.84M	46.74%-9.86M	55.83%-7.81M
Cash from discontinued investing activities
Operating cash flow	32.83%-102.83M	120.35%8.05M	7.65%-31.65M	9.57%-35.26M	-9.12%-43.97M	-18.72%-153.09M	-3.09%-39.54M	8.03%-34.27M	-27.77%-38.99M	-76.55%-40.3M
Investing cash flow
Cash flow from continuing investing activities	581.74%139.89M	138.16%18.95M	261.44%60.51M	-56.19%35.84M	-4.95%24.58M	120.55%20.52M	26.98%-49.67M	72.61%-37.48M	34.72%81.8M	-41.65%25.86M
Net PPE purchase and sale	-1,115.80%-34.48M	-3,016.62%-11.63M	-548.31%-8.08M	-1,365.03%-10.77M	-731.74%-4.01M	-77.58%-2.84M	25.55%-373K	-307.19%-1.25M	-17.41%-735K	-193.90%-482K
Net investment purchase and sale	646.59%174.37M	162.03%30.58M	289.29%68.59M	-43.53%46.61M	8.53%28.59M	123.77%23.36M	26.99%-49.29M	73.47%-36.24M	34.54%82.54M	-40.78%26.35M
Cash from discontinued investing activities
Investing cash flow	581.74%139.89M	138.16%18.95M	261.44%60.51M	-56.19%35.84M	-4.95%24.58M	120.55%20.52M	26.98%-49.67M	72.61%-37.48M	34.72%81.8M	-41.65%25.86M
Financing cash flow
Cash flow from continuing financing activities	-97.26%4.19M	-0.97%1.93M	-100.14%-206K	258.52%1.31M	526.49%1.16M	-38.87%153M	-4.92%1.95M	-38.83%150.5M	-77.14%364K	-68.91%185K
Net issuance payments of debt	93.27%-76K	403.28%925K	-16.44%-340K	-24.16%-334K	-23.86%-327K	-33.10%-1.13M	-95.51%-305K	17.05%-292K	-44.62%-269K	-70.32%-264K
Net common stock issuance	--0	--0	----	----	----	-38.37%149.83M	--0	----	----	----
Proceeds from stock option exercised by employees	-0.84%4.27M	-55.31%1.01M	-86.10%134K	158.93%1.64M	230.96%1.49M	-48.88%4.3M	0.85%2.26M	-70.39%964K	-64.40%633K	-60.85%449K
Cash from discontinued financing activities
Financing cash flow	-97.26%4.19M	-0.97%1.93M	-100.14%-206K	258.52%1.31M	526.49%1.16M	-38.87%153M	-4.92%1.95M	-38.83%150.5M	-77.14%364K	-68.91%185K
Net cash flow
Beginning cash position	37.77%74.53M	-46.32%86.85M	-29.92%58.19M	41.30%56.3M	37.77%74.52M	65.96%54.09M	2.12%161.77M	-4.01%83.03M	-27.14%39.85M	65.96%54.09M
Current changes in cash	101.89%41.25M	133.16%28.93M	-63.61%28.66M	-95.63%1.89M	-27.92%-18.23M	-4.96%20.43M	16.36%-87.25M	9.50%78.75M	35.78%43.18M	-164.48%-14.25M
End cash Position	55.35%115.78M	55.35%115.78M	-46.32%86.85M	-29.92%58.19M	41.30%56.3M	37.77%74.53M	37.77%74.53M	2.12%161.77M	-4.01%83.03M	-27.14%39.85M
Free cash flow	11.94%-137.31M	91.03%-3.58M	-11.85%-39.73M	-15.87%-46.02M	-17.66%-47.98M	-19.44%-155.92M	-2.72%-39.91M	5.46%-35.52M	-27.57%-39.72M	-77.39%-40.78M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall